140 related articles for article (PubMed ID: 6177535)
1. Serum beta-2-microglobulin in multiple myeloma: relation to presenting features and clinical status.
Bataille R; Magub M; Grenier J; Donnadio D; Sany J
Eur J Cancer Clin Oncol; 1982 Jan; 18(1):59-66. PubMed ID: 6177535
[TBL] [Abstract][Full Text] [Related]
2. Beta 2 microglobulin in multiple myeloma.
Alexanian R; Barlogie B; Fritsche H
Am J Hematol; 1985 Dec; 20(4):345-51. PubMed ID: 3907332
[TBL] [Abstract][Full Text] [Related]
3. [Serum beta 2-microglobulin in multiple myeloma. II. Its significance in monitoring the disease].
Scudla V; Budíková M; Fischerová E; Raska I; Vavrdová V
Vnitr Lek; 1991 May; 37(5):479-87. PubMed ID: 1842146
[TBL] [Abstract][Full Text] [Related]
4. Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patients.
Bataille R; Grenier J; Sany J
Blood; 1984 Feb; 63(2):468-76. PubMed ID: 6362753
[TBL] [Abstract][Full Text] [Related]
5. [Serum beta-2-microglobulin in multiple myeloma. Practical value].
Bataille R; Magub M; Sany J; Donadio D; Izarn P; Grenier J; Suquet P
Rev Rhum Mal Osteoartic; 1981 Mar; 48(3):235-40. PubMed ID: 6164091
[TBL] [Abstract][Full Text] [Related]
6. [Value of the determination of beta-2-microglobulin in the monitoring of myeloma. Apropos of 290 determinations].
Kaltwasser P; Sauger F; Le Loet X; Pasquis P; Monconduit M; Deshayes P
Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):359-63. PubMed ID: 6179150
[TBL] [Abstract][Full Text] [Related]
7. Unexpected normal serum beta-microglobulin (B2M) levels in multiple myeloma.
Bataille R; Grenier J; Sany J
Anticancer Res; 1987; 7(3 Pt B):513-5. PubMed ID: 3307602
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum beta 2-microglobulin as a prognostic indicator in myelomatosis.
Child JA; Crawford SM; Norfolk DR; O'Quigley J; Scarffe JH; Struthers LP
Br J Cancer; 1983 Jan; 47(1):111-4. PubMed ID: 6185132
[TBL] [Abstract][Full Text] [Related]
9. Serum beta-2-microglobulin in the differential diagnosis of monoclonal gammopathies.
Elias J; Dauth J; Senekal JC; van der Walt P; Joubert HF; Kühn F; Greenacre M
S Afr Med J; 1991 Jun; 79(11):650-3. PubMed ID: 2047946
[TBL] [Abstract][Full Text] [Related]
10. Beta 2-microglobulin in monoclonal gammopathies.
Vercelli D; Cozzolino F; Becucci A; Di Guglielmo R
Nouv Rev Fr Hematol (1978); 1982; 24(2):85-8. PubMed ID: 6180380
[No Abstract] [Full Text] [Related]
11. Serum beta 2-microglobulin: a real improvement in the management of multiple myeloma?
van Dobbenburgh OA; Rodenhuis S; Ockhuizen T; Weltevreden E; Houwen B; Fidler V; Meijer S; Marrink J
Br J Haematol; 1985 Dec; 61(4):611-20. PubMed ID: 3910076
[TBL] [Abstract][Full Text] [Related]
12. Serum ferritin and beta 2-microglobulin in patients with multiple myeloma.
Linkesch W; Ludwig H
Cancer Detect Prev; 1983; 6(1-2):297-301. PubMed ID: 6192921
[TBL] [Abstract][Full Text] [Related]
13. Serum beta-2-microglobulin in patients with multiple myeloma treated with alpha interferon.
Murakami H; Ogawara H; Morita K; Saitoh T; Matsushima T; Tamura J; Sawamura M; Karasawa M; Miyawaki S; Schimano S; Satoh S; Tsuchiya J
J Med; 1997; 28(5-6):311-8. PubMed ID: 9604789
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic implications of myeloma staging.
Durie BG; Bataille R
Eur J Haematol Suppl; 1989; 51():111-6. PubMed ID: 2697583
[TBL] [Abstract][Full Text] [Related]
15. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI.
D'Anastasi M; Notohamiprodjo M; Schmidt GP; Dürr HR; Reiser MF; Baur-Melnyk A
AJR Am J Roentgenol; 2014 Oct; 203(4):854-62. PubMed ID: 25247952
[TBL] [Abstract][Full Text] [Related]
16. [Radioimmunoassay of beta2-microglobulin in monoclonal gammopathies (author's transl)].
Fateh-Moghadam A; Mantel W; Sandel P; von Stetten K
Dtsch Med Wochenschr; 1978 Oct; 103(43):1703-6. PubMed ID: 81126
[TBL] [Abstract][Full Text] [Related]
17. Serum beta 2-microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disorders.
Garewal H; Durie BG; Kyle RA; Finley P; Bower B; Serokman R
J Clin Oncol; 1984 Jan; 2(1):51-7. PubMed ID: 6366146
[TBL] [Abstract][Full Text] [Related]
18. Beta-2-microglobulin is an independent predictor of progression in asymptomatic multiple myeloma.
Rossi D; Fangazio M; De Paoli L; Puma A; Riccomagno P; Pinto V; Zigrossi P; Ramponi A; Monga G; Gaidano G
Cancer; 2010 May; 116(9):2188-200. PubMed ID: 20198709
[TBL] [Abstract][Full Text] [Related]
19. [Serum ferritin and beta-2-microglobulin in multiple myeloma].
Linkesch W; Ludwig H
Acta Med Austriaca; 1982; 9(5-6):227-31. PubMed ID: 6187172
[TBL] [Abstract][Full Text] [Related]
20. [Serum beta 2-microglobulin in multiple myeloma. I. Relation to selected indicators, clinical stage and disease prognosis].
Scudla V; Budíková M; Fischerová E; Raska I; Vavrdová V
Vnitr Lek; 1991 Apr; 37(4):342-51. PubMed ID: 2053304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
